Cellular Cytotoxicity of Next Generation CD20 Monoclonal Antibodies

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-18-0319
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Developing the Next Generation of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis

British Journal of Pharmacology
Pharmacology
2011English

Generation of Med28 Specific Monoclonal Antibodies

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
AllergyImmunology
2015English

Reactive Oxygen Species Induced by Therapeutic CD20 Antibodies Inhibit Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against Primary CLL Cells

Oncotarget
Oncology
2016English

Generation of Monoclonal Antibodies to Integrin-Associated Proteins

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies

Viruses
VirologyInfectious Diseases
2019English

Generation and Characterization of Monoclonal Antibodies to Equine NKp46

Veterinary Immunology and Immunopathology
VeterinaryImmunology
2012English

In Vivo Cellular Reprogramming: The Next Generation

Cell
BiochemistryGeneticsMolecular Biology
2016English

Generation and Characterization of Monoclonal Antibodies Specific toDrosophila Presenilin

Hybridoma
2009English

Generation of Bispecific Monoclonal Antibodies for Two Phase Radioimmunotherapy

British Journal of Cancer
Cancer ResearchOncology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy